➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
AstraZeneca
Colorcon
Harvard Business School
Merck

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

VIBRAMYCIN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Vibramycin, and when can generic versions of Vibramycin launch?

Vibramycin is a drug marketed by Pfizer and is included in four NDAs.

The generic ingredient in VIBRAMYCIN is doxycycline calcium. There are twenty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxycycline calcium profile page.

Drug patent expirations by year for VIBRAMYCIN
Drug Prices for VIBRAMYCIN

See drug prices for VIBRAMYCIN

Drug Sales Revenue Trends for VIBRAMYCIN

See drug sales revenues for VIBRAMYCIN

Recent Clinical Trials for VIBRAMYCIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
BioMed Valley Discoveries, IncPhase 1
Merck Sharp & Dohme Corp.Phase 1
M.D. Anderson Cancer CenterPhase 1

See all VIBRAMYCIN clinical trials

Pharmacology for VIBRAMYCIN

US Patents and Regulatory Information for VIBRAMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer VIBRAMYCIN doxycycline hyclate CAPSULE;ORAL 050007-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Pfizer VIBRAMYCIN doxycycline hyclate INJECTABLE;INJECTION 050442-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Pfizer VIBRAMYCIN doxycycline hyclate CAPSULE;ORAL 050007-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pfizer VIBRAMYCIN doxycycline FOR SUSPENSION;ORAL 050006-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pfizer VIBRAMYCIN doxycycline calcium SUSPENSION;ORAL 050480-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Express Scripts
Baxter
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.